Rapid Shifts Accelerate the Growth of the US Ambulatory Surgery Centers
Future growth potential of ambulatory surgery centers increases opportunities for Medtech
Click image to view it in full size
The shift of surgery volumes from inpatient to outpatient has been ongoing for a while, owing to lower costs. As more volume of procedures moves to the ASC setting (at 20+% over the next few years, per some estimates), there are several considerations for medtech companies (and admittedly for other healthcare stakeholders as well).
From customized device portfolios for ASCs as the customer, to developing partnerships with them, there are various ways that medtech companies will need to change their approach to succeed. While each clinical specialty will show varying nuances in terms of the extent of the shift to outpatient, and the share of ASCs (as against with HOPDs, or physician offices), without a doubt, ASCs will still be an important, hard-to-ignore customer segment in the coming years.
Take your first step towards achieving growth-centric solutions with our
Growth Pipeline Dialog™. Speak to our industry experts in a complimentary open discussion that will spark innovative thinking and growth opportunities that will benefit your organization.
